BREYANZI

Juno Therapeutics, Inc.

Application Filed: 2018-08-14
Trademark Application Details
Trademark Logo BREYANZI

Mark For: BREYANZI® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use. [all]

Status

2020-11-12 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number88077381
Registration Number5709663
Mark Literal ElementsBREYANZI
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2019-03-26
Basis44(e)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUYes
44D FiledYes
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameCamille M. Miller
Attorney Docket Number426675/CELG-
Law Office AssignedL90
Employee NameSOBRAL, CHRISTINA

Timeline

2018-08-14Application Filed
2018-12-03Location: PUBLICATION AND ISSUE SECTION
2019-01-08Published
2019-01-08Published for Opposition
2019-01-08Status: Live/Pending
2019-01-08Transaction Date
2019-03-26Location: PUBLICATION AND ISSUE SECTION
2019-03-26Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2019-03-26Trademark Registered
2024-03-26Maintenance Early File Date
2025-03-26Maintenance On Time Date
2025-09-26Maintenance Late Fee Date

Trademark Parties (Applicants & Owners)

Party: JUNO THERAPEUTICS, INC.
Address400 DEXTER AVENUENORTH SUITE 1200 SEATTLE, WASHINGTON UNITED STATES 98109
Legal Entity TypeCorporation
Legal Entity StateDELAWARE
Party: Celgene Corporation
Address86 Morris Avenue Summit DE 07901
Legal Entity Type
Legal Entity StateDE

*multiple parties listed, check assignment documents for ownership information

Attorney of Record

CAMILLE M. MILLER
COZEN O'CONNOR
ONE LIBERTY PLACE
1650 MARKET STREET, SUITE 2800
PHILADELPHIA, PA 19103

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
GS0051Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use

Assignments

Trademark Filing History

DescriptionDateProceeding Number
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2019-10-30
REGISTERED-PRINCIPAL REGISTER2019-03-26
PUBLISHED FOR OPPOSITION2019-01-08
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-01-08
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2018-12-19
ASSIGNED TO EXAMINER2018-11-3083185
APPROVED FOR PUB - PRINCIPAL REGISTER2018-11-30
ASSIGNED TO LIE2018-11-2870633
TEAS VOLUNTARY AMENDMENT RECEIVED2018-11-20
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-08-22
NEW APPLICATION ENTERED IN TRAM2018-08-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed